磺培南依扎罗西

磺培南依扎罗西（CAS 1000296-70-7）的公开数据库记录，列此仅供独立核对。

这个物质在各数据库里的编号

数据库记载的用途

• Sulopenem etzadroxil is indicated in combination with [probenecid] for the treatment of uncomplicated urinary tract infections caused by _Escherichia coli_, _Klebsiella pneumoniae_, or _Proteus mirabilis_ in adult women who have limited or no alternative oral antibacterial treatment options.
• Take with food. The absorption of sulopenem is improved when administered with a meal.
• Following rapid conversion into the active moiety, sulopenem bioavailability is approximately 40% in the fasted state, increasing to 64% when administered with a meal.
• Following a single oral dose of radiolabeled sulopenem etzadroxil in healthy adult subjects, 44.3% of radioactive product was recovered in the feces (26.9% as unchanged sulopenem) and 40.8% was recovered in the urine (3.1% as unchanged sulopenem).
• In the fasted state, the apparent volume of distribution of sulopenem is 134 liters. When administered with a high-fat meal, the apparent volume of distribution is 92.09 liters.
• In the fasted state, the apparent clearance of sulopenem is 77.6 L/h. When administered with a high-fat meal, the apparent clearance is 50.55 L/h.

它在各数据库里的别名

SULOPENEM ETZADROXIL; 1000296-70-7; Sulopenem etzadroxil (USAN); Sulopenem etzadroxil [USAN]; 492M3I304T; PF-03709270; PF03709270; UNII-492M3I304T; RefChem:186740; PF 03709270; PF 03709270 (ulopenem etzadroxil); sulopenem-etzadroxil; SCHEMBL3412832; Sulopenem etzadroxil [WHO-DD]; DTXSID80635293; NBPVNGWRLGHULH-CSOWVJSESA-N

计算机算出的分子描述符

数据库摘要

Sulopenem Etzadroxil · CAS 1000296-70-7 · C19H27NO7S3. UNII 492M3I304T.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。